ArticleCureus2026
Delayed-Onset Autoimmune Hemolytic Anemia in Advanced HIV With Cerebral Toxoplasmosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hemolytic anemia (AIHA) is an uncommon immune-mediated complication of human immunodeficiency virus (HIV) infection and represents a rare cause of anemia in this population. While anemia in HIV is typically multifactorial, AIHA has most often been reported early in the disease course or around the initiation of antiretroviral therapy. Delayed-onset AIHA developing during prolonged hospitalization is rarely described, particularly in patients with advanced immunosuppression. We report a case of delayed-onset warm AIHA occurring more than two months after admission in a patient with newly diagnosed advanced HIV infection complicated by cerebral toxoplasmosis. The patient developed acute hemolysis with laboratory evidence of immune-mediated destruction of erythrocytes after a period of clinical stability. Secondary causes of hemolysis were excluded, and the patient demonstrated a favorable response to corticosteroid therapy without relapse. This case highlights that AIHA may occur late during hospitalization, including during periods of partial immune recovery following antiretroviral therapy. Clinicians should maintain a high index of suspicion for immune-mediated hemolysis in patients with HIV who develop unexplained anemia. Further studies are needed to better understand the mechanisms underlying delayed-onset AIHA and its relationship to immune reconstitution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.